C57BL/6NTac-Raf1tm1a(EUCOMM)Wtsi/IcsOrl

Status

Available to order

EMMA IDEM:07652
International strain nameC57BL/6NTac-Raf1tm1a(EUCOMM)Wtsi/IcsOrl
Alternative nameEPD0065_4_B07
Strain typeTargeted Mutant Strains
Allele/Transgene symbolRaf1tm1a(EUCOMM)Wtsi
Gene/Transgene symbolRaf1
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0065_4_B07. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6N Tac, wild-type C57BL/6N Tac
Stage of embryos8-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • abnormal lens morphology / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • cataract / IMPC
MGI phenotypes (gene matching)
  • increased leukocyte cell number / MGI
  • increased neutrophil cell number / MGI
  • increased monocyte cell number / MGI
  • enlarged heart / MGI
  • distended pericardium / MGI
  • decreased cell proliferation / MGI
  • small hair follicles / MGI
  • underdeveloped hair follicles / MGI
  • ruffled hair / MGI
  • increased cranium width / MGI
  • flattened snout / MGI
  • liver hypoplasia / MGI
  • small liver / MGI
  • pale liver / MGI
  • abnormal hepatocyte morphology / MGI
  • enlarged spleen / MGI
  • tremors / MGI
  • abnormal epidermal layer morphology / MGI
  • thin epidermis / MGI
  • abnormal epidermis stratum corneum morphology / MGI
  • abnormal dermal layer morphology / MGI
  • thin dermal layer / MGI
  • decreased body length / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • ocular hypertelorism / MGI
  • eyelids open at birth / MGI
  • abnormal retina morphology / MGI
  • hunched posture / MGI
  • abnormal cardiovascular system physiology / MGI
  • anemia / MGI
  • abnormal vasculogenesis / MGI
  • cardiac hypertrophy / MGI
  • abnormal apoptosis / MGI
  • abnormal somite development / MGI
  • decreased embryo size / MGI
  • abnormal placenta morphology / MGI
  • abnormal placenta development / MGI
  • abnormal placenta labyrinth morphology / MGI
  • absent vitelline blood vessels / MGI
  • embryonic growth arrest / MGI
  • hemorrhage / MGI
  • respiratory failure / MGI
  • prenatal lethality / MGI
  • premature death / MGI
  • abnormal neural tube morphology / MGI
  • no abnormal phenotype detected / MGI
  • abnormal pulmonary alveolus morphology / MGI
  • dilated cardiomyopathy / MGI
  • increased heart weight / MGI
  • thick ventricular wall / MGI
  • no phenotypic analysis / MGI
  • cardiac fibrosis / MGI
  • increased cardiac output / MGI
  • small lung / MGI
  • pallor / MGI
  • abnormal facial morphology / MGI
  • increased left ventricle systolic pressure / MGI
  • abnormal heart left ventricle morphology / MGI
  • embryonic growth retardation / MGI
  • abnormal spongiotrophoblast layer morphology / MGI
  • small placenta / MGI
  • increased response of heart to induced stress / MGI
  • enlarged myocardial fiber / MGI
  • decreased placenta weight / MGI
  • decreased cardiac muscle contractility / MGI
  • cardiovascular system phenotype / MGI
  • hematopoietic system phenotype / MGI
  • increased cardiac muscle contractility / MGI
  • cardiac interstitial fibrosis / MGI
  • increased apoptosis / MGI
  • embryonic lethality during organogenesis / MGI
  • abnormal common myeloid progenitor cell morphology / MGI
  • decreased cranium height / MGI
  • decreased cranium width / MGI
  • enlarged heart right atrium / MGI
  • increased heart ventricle size / MGI
  • abnormal placental labyrinth vasculature morphology / MGI
  • increased sensitivity to induced cell death / MGI
  • decreased sensitivity to induced cell death / MGI
  • abnormal liver sinusoid morphology / MGI
  • decreased embryo weight / MGI
  • decreased fetal weight / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • abnormal cranium size / MGI
  • increased heart left ventricle size / MGI
  • thick interventricular septum / MGI
  • abnormal heart left ventricle pressure / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • decreased fibroblast proliferation / MGI
  • increased cardiac stroke volume / MGI
  • decreased spongiotrophoblast size / MGI
  • increased hepatoblast apoptosis / MGI
  • increased fibroblast apoptosis / MGI
  • increased embryonic tissue cell apoptosis / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).